1️⃣ Healthcare PE gets a $21B specialist GHO Capital and CBC Group signed a merger agreement to create a dedicated healthcare investment manager with more than $21 billion in AUM, 200+ professionals and 13 offices across North America, Europe and Asia-Pacific.
💡 Why it matters Specialist healthcare capital is scaling geographically. For assets with US, EU and Asia optionality, the buyer map just got more concentrated.
☕ Coffee talk How many mid-market healthcare funds can still call themselves global after this?
2️⃣ BARDA reaches for an Ebola antibody Reuters reported that U.S. officials are working with Mapp Biopharmaceutical to make an investigational monoclonal antibody available for high-risk people potentially exposed to Bundibugyo Ebola.
💡 Why it matters Bundibugyo has no approved vaccine or specific treatment. The live procurement signal is that biodefense platforms matter most when strain coverage is missing.
☕ Coffee talk Who else has an old outbreak asset that suddenly looks under-owned?
3️⃣ Medicare AI prior auth hits Congress Reps. Greg Landsman and Suzan DelBene said they are leading a Congressional Review Act resolution to overturn CMS’s WISeR model, the AI-supported prior authorization test running in six traditional Medicare states through 2031.
💡 Why it matters Utilization management is becoming a policy fight, not just an operations tool. Any vendor selling AI into reimbursement workflows now has political risk in the model.
☕ Coffee talk If Congress can force a vote on WISeR, which payer automation pilots stop looking like pilots?